Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Moodys
Johnson and Johnson
Medtronic
Merck
Harvard Business School
Express Scripts

Last Updated: November 13, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Seltorexant

See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Seltorexant?

Seltorexant is an investigational drug.

There have been 5 clinical trials for Seltorexant. The most recent clinical trial was a Phase 1 trial, which was initiated on September 1st 2017.

The most common disease conditions in clinical trials are Depressive Disorder, Major, Depressive Disorder, and Depression. The leading clinical trial sponsors are Janssen Research & Development, LLC, Minerva Neurosciences, and [disabled in preview].

There are three US patents protecting this investigational drug and fifty-two international patents.

Recent Clinical Trials for Seltorexant
TitleSponsorPhase
A Study to Assess the Effect of Seltorexant Compared to Placebo on Respiration During Sleep in Adult Participants With Obstructive Sleep ApneaJanssen Research & Development, LLCPhase 1
A Study of Seltorexant (JNJ-42847922) After Single-Dose Administration in Healthy ParticipantsMinerva NeurosciencesPhase 1
A Study of Seltorexant (JNJ-42847922) After Single-Dose Administration in Healthy ParticipantsJanssen Research & Development, LLCPhase 1

See all Seltorexant clinical trials

Clinical Trial Summary for Seltorexant

Top disease conditions for Seltorexant
Top clinical trial sponsors for Seltorexant

See all Seltorexant clinical trials

US Patents for Seltorexant

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Seltorexant   Start Trial Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators Janssen Pharmaceutica (BE)   Start Trial
Seltorexant   Start Trial Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators Janssen Pharmaceutica NV (BE)   Start Trial
Seltorexant   Start Trial Disubstituted octahydropyrrolo [3,4-C] pyrroles as orexin receptor modulators Janssen Pharmaceutica NV (Beerse, BE)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Seltorexant

Drugname Country Document Number Estimated Expiration Related US Patent
Seltorexant Argentina 078731 2029-10-23   Start Trial
Seltorexant Australia 2010310595 2029-10-23   Start Trial
Seltorexant Australia 2015242975 2029-10-23   Start Trial
Seltorexant Brazil 112012010820 2029-10-23   Start Trial
Seltorexant Canada 2778484 2029-10-23   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
AstraZeneca
Mallinckrodt
Johnson and Johnson
Baxter
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.